SMART: A Breath-based Adherence Technology to Monitor HIV Microbicide Gel Use
SMART: A Breath-based Adherence Technology to Monitor HIV Microbicide Gel Use
批准号:
8659647
负责人:
DONN MICHAEL DENNIS
金额:
$31.13万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-04-01 至 2016-03-31
关键词:
2-butanolAdherenceBehaviorBehavioralBeveragesBiological AvailabilityBlindedCellular PhoneClinical InvestigatorClinical TrialsCommunicationCrossover DesignDataData SetDatabasesDevelopmentDevicesDiagnosticDirectly Observed TherapyDoseEconomicsExhalationFDA approvedFaceFacultyFloridaFoodGasesGelGenerationsGlycerolGoldGrantHIVHealth Insurance Portability and Accountability ActImageIndividualIndustryIngestionInternationalInternetIntravaginal AdministrationLegal patentLicensingMeasurementMeasuresMicrobicide Trials NetworkModelingMonitorNational Institute of Mental HealthOralParticipantPharmaceutical PreparationsPhasePilot ProjectsPlacebosPositioning AttributeProcessProductionProphylactic treatmentRaceReportingResearch PersonnelRouteSafetySalesSamplingSelf-AdministeredSmall IntestinesStomachSyringesSystemTechnologyTenofovirTestingTherapeuticTimeUniversitiesVaginaWireless TechnologyWomanWorkWorkplacebasedesigndrug efficacymanufacturing processmedication compliancemenmethylethyl ketonemicrobicidepre-clinicalpublic health relevancequality assurancerectalresidencesocioeconomicstime usetooltrait
中文摘要
描述(由申请人提供):在HIV暴露前预防(PrEP)试验中,次优的口服和杀微生物剂依从性妨碍了对药物疗效的准确估计。依从性的测量是一个重大的、尚未解决的挑战。对杀微生物剂试验中依从性的其他客观衡量标准已经进行了测试,但没有一个衡量产品的实际使用情况。我们建议利用已经开发的口服给药技术,为研究杀微生物剂给药的研究人员快速开发一种替代的、基于呼吸的依从性监测工具。Xhale开发了一种基于呼吸的技术,称为SMART(R)(自我监测和报告治疗)依从性系统,使用fda批准的GRAS调味剂作为依从性使能标记(AEM),实时监测个体受试者,逐个剂量,口服药物依从性。AEM(例如,2-丁醇)很容易和安全地加入到药品中,而不会改变其制造工艺或生物利用度,在胃和小肠中迅速吸收,并代谢为挥发性代谢物(例如,2-丁醇),迅速出现在呼吸中。当受试者通过直接向SMART(R)设备(微型气相色谱仪,mGC)“吹”提供呼吸样本时,会拍摄面部照片。mGC对这种代谢物的测量明确地记录了特定个体口服药物的摄入情况。详细的试验数据本地存储在mGC设备中,并使用无线或蜂窝路由器技术实时传输到中央数据存储库进行分析。后者是一个基于互联网的数据库,供全球任何地方有互联网连接的授权个人审查。SMART(R)是便携式的,设计为受试者自行管理。虽然最初是为口服药物设计的,但SMART(R)可以很容易地用于记录杀微生物剂的放置。使用替诺福韦(TFV)凝胶作为模型剂,本赠款的目的是构建一个针对杀微生物剂应用进行优化的SMART(R)系统:目标1。在男性(直肠途径)和女性(直肠和阴道途径)中采用交叉设计,确定杀菌剂应用的最佳AEM(类型和剂量)。(时间:0-12个月)制定策略(即多管注射器),以有效地将最佳AEM纳入直肠和阴道TFV凝胶的放置,而不需要改变其制造工艺,并保持良好的呼吸标记物浓度-时间分布。(时间:12-24个月)优化SMART(R)设备的杀菌剂应用。(时间:0-24个月)使用SMART(R)测量杀微生物剂粘附性,通过提供实时可操作的粘附性数据,可以对PrEP试验进行最佳分析。通过提供一个“金标准”工具来监测杀微生物剂的依从性,SMART(R)不仅可以提供一个优越的试验数据集,还可以用来识别与依从性差相关的行为,并制定缓解这些行为的策略。1
英文摘要
DESCRIPTION (provided by applicant): In HIV pre-exposure prophylaxis (PrEP) trials sub-optimal oral and microbicide adherence has precluded accurate estimation of drug efficacy. Measurement of adherence is a major, unmet challenge. Other objective measures of adherence in microbicide trials have been tested, but none measure the actual use of the product. We propose to rapidly develop an alternative, breath-based, adherence monitoring tool for investigators studying microbicide administration by leveraging technology already developed for oral dosing. Xhale has developed a breath-based technology, termed the SMART(R) (Self Monitoring and Reporting Therapeutics) Adherence System, to monitor individual subject, dose-by-dose, oral medication adherence in real-time using FDA-approved GRAS flavorants as the adherence enabling marker (AEM). The AEM (e.g., 2- butanol), which is easily and safely incorporated into drug product without altering its manufacturing processes or bioavailability, is rapidly absorbed in the stomach and small intestine, and metabolized to a volatile metabolite (e.g., 2-butanone) that quickly appears in breath. As the subject provides a breath sample by "blowing" directly into the SMART(R) device (miniature gas chromatograph, mGC), a facial picture is taken. Measurement of this metabolite(s) by the mGC unambiguously documents ingestion of oral drugs by a specific individual. Detailed trial data is stored locally i the mGC device and transmitted real-time using wireless or cellular router technology to a central data repository for analysis. The latter is an internet-based database for review by authorized individuals anywhere on the globe with an internet connection. SMART(R) is portable and designed to be self-administered by subjects. Although originally designed for oral drugs, SMART(R) can be easily adapted to document placement of microbicides. Using tenofovir (TFV) gel as a model agent, the aims of this grant are to construct a SMART(R) system optimized for microbicide applications: Aim 1. Using a crossover design in men (rectal route) and women (rectal and vaginal routes), identify an optimal AEM (type and dose) for microbicide applications. (Time: 0-12 months) Aim 2. Develop strategies (i.e., multiple-barrel syringe applicators) to effectively incorporate the optimal AEM into the placement of rectal and vaginal TFV gels that requires no change in their manufacturing processes, and preserves a favorable concentration-time profile of the breath marker. (Time: 12-24 months) Aim 3. Optimize the SMART(R) device for microbicide applications. (Time: 0-24 months) Measurement of microbicide adherence using SMART(R) would allow optimal analysis of PrEP trials by providing real-time actionable adherence data. By providing a "gold standard" tool to monitor microbicide adherence, SMART(R) could not only provide a superior trial dataset, but could also be used to identify behaviors associated with poor adherence and enable strategies to mitigate them. 1
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SMART: A Breath-based Adherence Technology to Monitor HIV Microbicide Gel Use
-
批准号:8829923
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2014
-
负责人:DONN MICHAEL DENNIS
-
依托单位:
A Breath-based Naltrexone Adherence Tool to Manage Narcotic-addicted HIV patients
-
批准号:8263470
-
项目类别:
-
资助金额:$16.32万
-
财政年份:2012
-
负责人:DONN MICHAEL DENNIS
-
依托单位:
Propofol in Exhaled Breath: Real-time Detection by Surface Acoustic Wave Sensors
-
批准号:8314868
-
项目类别:
-
资助金额:$16.11万
-
财政年份:2012
-
负责人:DONN MICHAEL DENNIS
-
依托单位:
Local Anesthetic Cardiotoxicity: Nanotechnology Therapy
-
批准号:7087698
-
项目类别:
-
资助金额:$25.01万
-
财政年份:2003
-
负责人:DONN MICHAEL DENNIS
-
依托单位:
Local Anesthetic Cardiotoxicity: Nanotechnology Therapy
-
批准号:6910675
-
项目类别:
-
资助金额:$25.61万
-
财政年份:2003
-
负责人:DONN MICHAEL DENNIS
-
依托单位:
Local Anesthetic Cardiotoxicity: Nanotechnology Therapy
-
批准号:6562963
-
项目类别:
-
资助金额:$27.72万
-
财政年份:2003
-
负责人:DONN MICHAEL DENNIS
-
依托单位:
Local Anesthetic Cardiotoxicity: Nanotechnology Therapy
-
批准号:6743187
-
项目类别:
-
资助金额:$25.58万
-
财政年份:2003
-
负责人:DONN MICHAEL DENNIS
-
依托单位:
海外基金